"Designing Growth Strategies is in our DNA"

Nanomedicine Market Size, Share & Industry Analysis, By Type (Therapeutics {Biologics and Small Molecules}, Diagnostics {IVD, Imaging, and Others}, and Medical Devices {Regenerative Medicine, and Implants}), By Molecule Type (Nanoparticles {Lipid Based, Polymers & Polymer Drug Conjugates, Inorganic Nanoparticles}, Nanoshells, Nanotubes, and Nanodevices) By Application (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Immunology, Infectious Diseases), By End-user (Hospitals and Clinics, Diagnostics Laboratories, Research and Academic Institutes), and Regional Forecast, 2025-2032

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI110983

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Unit

Value (USD billion)

Growth Rate

CAGR of 11.7% from 2025-2032

Segmentation

By Type

  • Therapeutics
    • Biologics
    • Small Molecules
  • Diagnostics
    • IVD
    • Imaging
    • Others
  • Medical Devices
    • Regenerative Medicine
    • Implants

By Molecule Type

  • Nanoparticles
    • Lipid-Based
    • Polymers & Polymer Drug Conjugates
    • Inorganic Nanoparticles
    • Others
  • Nanoshells
  • Nanotubes
  • Nanodevices

By Application

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Immunology
  • Infectious Diseases
  • Others

By End-user

  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Research and Academic Institutes
  • Others

By Geography

  • North America (By Type, By Molecule Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe ( By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America ( By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa ( By Type, By Molecule Type, By Application, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 200
Consulting Services
    How will you benefit from our consulting services ?